Phyrago

Active Ingredient(s): Dasatinib
FDA Approved: * December 5, 2023
Pharm Company: * NANOCOPOEIA
Category: Cancer

Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).[3] Specifically it is used to treat cases that are Philadelphia chromosome-positive (Ph+).[3] It is taken by mouth.[3] Common adverse effects include low white blood cells, low blood platelets, anemia, swelling, rash, and diarrhea.[3] ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Phyrago 20 mg Oral Tablet
NDC: 83858-101
Labeler:
Nanocopoeia
Phyrago 50 mg Oral Tablet
NDC: 83858-102
Labeler:
Nanocopoeia
Phyrago 70 mg Oral Tablet
NDC: 83858-103
Labeler:
Nanocopoeia
Phyrago 80 mg Oral Tablet
NDC: 83858-104
Labeler:
Nanocopoeia
Phyrago 100 mg Oral Tablet
NDC: 83858-105
Labeler:
Nanocopoeia
Phyrago 140 mg Oral Tablet
NDC: 83858-106
Labeler:
Nanocopoeia

Related Brands

Drugs with the same active ingredients